Clinical Trials Browser

Phase 1 × Interventional × Dalteparin × Clear all

NCT01061411 2022-08-05

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

Carcinoma, Renal Cell